title: Catecholamine metabolic pathways and exercise training. Plasma and urine catecholamines, metabolic enzymes, and chromogranin-A.
abstract: BACKGROUND
  Because acute exercise increases systemic catecholamines, we sought to determine whether exercise training would alter daily or exercise-related catecholamine release and inactivation.
  
  
  RESULTS
  In 24-hour urine collections, catecholamines and metabolites provided indexes of overall oxidative deamination, sulfation, and O-methylation. Plasma catecholamines, the sulfoconjugates of each, and chromogranin-A were determined at rest and during exercise in 10 well-trained male subjects and nine minimally trained male subjects (maximal oxygen uptake 55.2 and 42.5 ml/kg/min, respectively), and levels of activities of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAO-B), and thermolabile phenolsulfotransferase (TL-PST) were also determined. Plasma-free catecholamines showed minimal differences between the two groups at submaximal exercise (4 minutes) but large differences at maximal exercise, reflecting the different exercise levels attained. Inactivation of plasma catecholamines by sulfation across rest and exercise tended to be greater in the well-trained group, with small increases in both plasma sulfoconjugated dopamine and sulfoconjugated norepinephrine. In the well-trained group, urinary metabolites demonstrated trends toward increased dopamine release (p less than 0.07) and small increases in the daily release of epinephrine and its sulfoconjugated metabolites. Indexes of deamination, sulfoconjugation, and O-methylation, with the exception of a reduced deamination of dopamine and the activities of COMT, MAO-B, and TL-PST were not different in the two groups.
  
  
  CONCLUSIONS
  Despite considerable differences in the exercise activities per week between well-trained and minimally trained individuals, there were minimal differences in the release and metabolism of catecholamines at rest or during exercise.
authors.affiliation: Cardiovascular Division, Mayo Clinic, Rochester, Minn.
authors.forename: P J
authors.initials: PJ
authors.lastname: Rogers
authors.forename: G M
authors.initials: GM
authors.lastname: Tyce
authors.forename: R M
authors.initials: RM
authors.lastname: Weinshilboum
authors.forename: D T
authors.initials: DT
authors.lastname: O'Connor
authors.forename: K R
authors.initials: KR
authors.lastname: Bailey
authors.forename: A A
authors.initials: AA
authors.lastname: Bove
mesh_terms: D000328:Adult; D002394:Catechol O-Methyltransferase / Q000032:analysis; D002395:Catecholamines / Q000378:metabolism*; D053379:Chromogranin A; D002864:Chromogranins / Q000378:metabolism*; D015444:Exercise; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D010806:Physical Education and Training; D013464:Sulfuric Acids / Q000378:metabolism
chemical_list: C506150:CHGA protein, human; D002395:Catecholamines; D053379:Chromogranin A; D002864:Chromogranins; D013464:Sulfuric Acids; D002394:Catechol O-Methyltransferase; D006719:Homovanillic Acid